Column Group LLC Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$81.0B

Holdings

5

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ORICORIC Pharmaceuticals Inc.
3,540,777$42.5B52.48%
2
SRZNSurrozen, Inc.
1,499,773$19.3B23.88%
3
TNYATenaya Therapeutics, Inc.
9,400,290$14.9B18.35%
4
RAPTEURRAPT Therapeutics Inc
166,075$4.3B5.29%
5
RVMDRevolution Medicines Inc
46$2.1M0.00%